Incidental Mutation 'R3854:Acvr1'
ID 276048
Institutional Source Beutler Lab
Gene Symbol Acvr1
Ensembl Gene ENSMUSG00000026836
Gene Name activin A receptor, type 1
Synonyms Alk8, Tsk7L, SKR1, D330013D15Rik, ActRIA, ALK2, Acvr1a, Acvr, Alk-2, Acvrlk2, ActR-I
MMRRC Submission 041605-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R3854 (G1)
Quality Score 221
Status Validated
Chromosome 2
Chromosomal Location 58336450-58456840 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 58352946 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Lysine to Arginine at position 338 (K338R)
Ref Sequence ENSEMBL: ENSMUSP00000108220 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000056376] [ENSMUST00000090935] [ENSMUST00000112599] [ENSMUST00000112601]
AlphaFold P37172
Predicted Effect probably damaging
Transcript: ENSMUST00000056376
AA Change: K338R

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000056784
Gene: ENSMUSG00000026836
AA Change: K338R

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably damaging
Transcript: ENSMUST00000090935
AA Change: K338R

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000088453
Gene: ENSMUSG00000026836
AA Change: K338R

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably damaging
Transcript: ENSMUST00000112599
AA Change: K338R

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000108218
Gene: ENSMUSG00000026836
AA Change: K338R

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 1.4e-13 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably damaging
Transcript: ENSMUST00000112601
AA Change: K338R

PolyPhen 2 Score 0.997 (Sensitivity: 0.41; Specificity: 0.98)
SMART Domains Protein: ENSMUSP00000108220
Gene: ENSMUSG00000026836
AA Change: K338R

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect noncoding transcript
Transcript: ENSMUST00000145495
Meta Mutation Damage Score 0.8798 question?
Coding Region Coverage
  • 1x: 99.6%
  • 3x: 98.8%
  • 10x: 97.2%
  • 20x: 94.2%
Validation Efficiency 96% (46/48)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous inactivation of this gene leads to embryonic growth arrest and complete embryonic lethality due to gastrulation defects associated with abnormalities in primitive streak formation, embryonic epiblast morphology, and mesoderm and ectoderm development. [provided by MGI curators]
Allele List at MGI

All alleles(12) : Targeted, knock-out(4) Targeted, other(3) Gene trapped(5)

Other mutations in this stock
Total: 44 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adar C T 3: 89,643,565 (GRCm39) P482L probably damaging Het
Adh5 A G 3: 138,156,776 (GRCm39) D154G probably benign Het
Apoa1 A G 9: 46,141,521 (GRCm39) S206G probably benign Het
Aspdh T C 7: 44,115,613 (GRCm39) V5A possibly damaging Het
Bend3 AAGGACCA AA 10: 43,386,713 (GRCm39) probably benign Het
C2cd3 A T 7: 100,103,808 (GRCm39) probably null Het
Ccdc87 A G 19: 4,889,546 (GRCm39) I13V probably benign Het
Cd163 A T 6: 124,288,525 (GRCm39) N319Y probably damaging Het
Cdc42bpa A G 1: 179,983,543 (GRCm39) probably benign Het
Ceacam2 T C 7: 25,238,227 (GRCm39) S66G probably benign Het
Cep131 G A 11: 119,958,011 (GRCm39) R772* probably null Het
Clhc1 T C 11: 29,521,789 (GRCm39) C441R probably damaging Het
Clstn2 G A 9: 97,345,648 (GRCm39) Q567* probably null Het
Cops7a C T 6: 124,936,795 (GRCm39) R252H probably damaging Het
Daam2 T C 17: 49,765,624 (GRCm39) N1093S probably benign Het
Dnajc16 G A 4: 141,490,964 (GRCm39) R729* probably null Het
Eml6 C T 11: 29,699,905 (GRCm39) A1744T possibly damaging Het
Fam43b G C 4: 138,122,409 (GRCm39) R304G probably benign Het
Fbll1 T A 11: 35,688,526 (GRCm39) T246S probably benign Het
Fbln2 A T 6: 91,243,353 (GRCm39) T910S probably damaging Het
Fcna C T 2: 25,517,784 (GRCm39) G22D possibly damaging Het
Gadl1 G T 9: 115,835,732 (GRCm39) E387* probably null Het
Gm5592 G A 7: 40,807,259 (GRCm39) probably benign Het
Gpr82 A T X: 13,531,577 (GRCm39) T42S probably benign Het
Hk2 T C 6: 82,713,657 (GRCm39) E447G possibly damaging Het
Idi1 G T 13: 8,935,968 (GRCm39) A25S probably benign Het
Lbr G A 1: 181,659,280 (GRCm39) T167I probably benign Het
Mdh1 C T 11: 21,509,281 (GRCm39) V234I probably benign Het
Muc2 A G 7: 141,308,081 (GRCm39) H420R probably damaging Het
Nhlrc2 T C 19: 56,576,703 (GRCm39) probably null Het
Nrcam G T 12: 44,622,667 (GRCm39) A938S probably benign Het
Nt5c2 A G 19: 46,884,957 (GRCm39) V252A probably damaging Het
Or10z1 T A 1: 174,077,716 (GRCm39) Y259F probably damaging Het
Or1p1c A T 11: 74,161,105 (GRCm39) K297* probably null Het
Or51r1 T G 7: 102,228,227 (GRCm39) L175R probably damaging Het
Pgap3 T C 11: 98,281,638 (GRCm39) T187A possibly damaging Het
Pus10 T C 11: 23,653,003 (GRCm39) probably null Het
Rnf213 T C 11: 119,371,765 (GRCm39) probably benign Het
Sag T C 1: 87,752,240 (GRCm39) probably benign Het
Serpinb9e A G 13: 33,439,137 (GRCm39) I188V probably benign Het
Shcbp1l A T 1: 153,328,190 (GRCm39) I634F probably damaging Het
Slc6a16 T A 7: 44,917,596 (GRCm39) C485S probably damaging Het
Vmn1r215 A C 13: 23,260,058 (GRCm39) M33L probably benign Het
Vps26c A G 16: 94,311,665 (GRCm39) F95L probably benign Het
Other mutations in Acvr1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00691:Acvr1 APN 2 58,337,585 (GRCm39) missense probably benign 0.00
IGL01392:Acvr1 APN 2 58,390,558 (GRCm39) missense probably benign 0.01
IGL01526:Acvr1 APN 2 58,348,997 (GRCm39) missense probably benign 0.20
IGL02524:Acvr1 APN 2 58,338,319 (GRCm39) splice site probably benign
IGL02682:Acvr1 APN 2 58,367,823 (GRCm39) missense probably benign 0.00
IGL02795:Acvr1 APN 2 58,352,964 (GRCm39) missense probably damaging 1.00
R0084:Acvr1 UTSW 2 58,348,895 (GRCm39) critical splice donor site probably null
R0452:Acvr1 UTSW 2 58,390,507 (GRCm39) missense probably benign 0.13
R0746:Acvr1 UTSW 2 58,390,562 (GRCm39) start codon destroyed probably null 0.01
R1484:Acvr1 UTSW 2 58,369,901 (GRCm39) missense probably damaging 1.00
R1514:Acvr1 UTSW 2 58,337,597 (GRCm39) nonsense probably null
R1645:Acvr1 UTSW 2 58,352,911 (GRCm39) missense probably damaging 1.00
R1925:Acvr1 UTSW 2 58,337,661 (GRCm39) missense probably damaging 0.99
R2435:Acvr1 UTSW 2 58,369,704 (GRCm39) missense probably damaging 1.00
R2873:Acvr1 UTSW 2 58,367,808 (GRCm39) nonsense probably null
R3729:Acvr1 UTSW 2 58,352,925 (GRCm39) missense probably null 0.09
R4438:Acvr1 UTSW 2 58,367,739 (GRCm39) missense probably benign 0.00
R4863:Acvr1 UTSW 2 58,367,723 (GRCm39) missense possibly damaging 0.60
R5543:Acvr1 UTSW 2 58,353,157 (GRCm39) missense probably damaging 1.00
R5558:Acvr1 UTSW 2 58,349,029 (GRCm39) missense probably damaging 1.00
R5618:Acvr1 UTSW 2 58,352,955 (GRCm39) missense probably damaging 1.00
R6233:Acvr1 UTSW 2 58,338,411 (GRCm39) missense probably benign 0.04
R6236:Acvr1 UTSW 2 58,367,678 (GRCm39) missense probably benign 0.17
R6565:Acvr1 UTSW 2 58,369,769 (GRCm39) missense probably damaging 1.00
R6912:Acvr1 UTSW 2 58,337,585 (GRCm39) missense probably benign 0.00
R7739:Acvr1 UTSW 2 58,352,983 (GRCm39) missense possibly damaging 0.47
R7912:Acvr1 UTSW 2 58,364,230 (GRCm39) missense probably damaging 0.97
R8127:Acvr1 UTSW 2 58,367,638 (GRCm39) missense probably benign 0.14
R8343:Acvr1 UTSW 2 58,364,286 (GRCm39) critical splice acceptor site probably null
R8688:Acvr1 UTSW 2 58,352,961 (GRCm39) missense probably damaging 0.98
R8876:Acvr1 UTSW 2 58,338,422 (GRCm39) missense possibly damaging 0.83
R9135:Acvr1 UTSW 2 58,352,983 (GRCm39) missense possibly damaging 0.47
R9290:Acvr1 UTSW 2 58,338,330 (GRCm39) missense probably damaging 1.00
R9562:Acvr1 UTSW 2 58,338,385 (GRCm39) missense probably damaging 1.00
R9565:Acvr1 UTSW 2 58,338,385 (GRCm39) missense probably damaging 1.00
Z1176:Acvr1 UTSW 2 58,369,880 (GRCm39) missense probably benign 0.00
Predicted Primers PCR Primer
(F):5'- ACTTGGCCTTCCTGAATGTTTG -3'
(R):5'- TTTCATCGCTTCAGACATGACC -3'

Sequencing Primer
(F):5'- GAAATTTTCAGCGTGACATGTTAGG -3'
(R):5'- ACTCCAGTACCCAGCTGTG -3'
Posted On 2015-04-06